Harmony Biosciences Holdings, Inc. (HRMY)
33.76
-0.04
(-0.12%)
USD |
NASDAQ |
Nov 13, 16:00
33.85
+0.09
(+0.27%)
After-Hours: 19:59
Harmony Biosciences Holdings Price to Book Value : 1.849 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.849 |
| November 12, 2026 | 1.851 |
| November 11, 2026 | 1.874 |
| November 10, 2026 | 1.837 |
| November 09, 2026 | 1.850 |
| November 06, 2026 | 1.813 |
| November 05, 2026 | 1.778 |
| November 04, 2026 | 1.885 |
| November 03, 2026 | 2.027 |
| November 02, 2026 | 2.076 |
| October 30, 2026 | 2.123 |
| October 29, 2026 | 2.113 |
| October 28, 2026 | 2.108 |
| October 27, 2026 | 2.078 |
| October 26, 2026 | 2.017 |
| October 23, 2026 | 1.979 |
| October 22, 2026 | 1.973 |
| October 21, 2026 | 2.098 |
| October 20, 2026 | 2.119 |
| October 19, 2026 | 2.056 |
| October 16, 2026 | 2.078 |
| October 15, 2026 | 2.096 |
| October 14, 2026 | 2.054 |
| October 13, 2026 | 2.028 |
| October 12, 2026 | 2.094 |
| Date | Value |
|---|---|
| October 09, 2026 | 2.206 |
| October 08, 2026 | 2.169 |
| October 07, 2026 | 2.154 |
| October 06, 2026 | 2.156 |
| October 05, 2026 | 2.186 |
| October 02, 2026 | 2.171 |
| October 01, 2026 | 2.167 |
| September 30, 2026 | 2.15 |
| September 29, 2026 | 2.285 |
| September 28, 2026 | 2.327 |
| September 25, 2026 | 2.400 |
| September 24, 2026 | 2.394 |
| September 23, 2026 | 2.354 |
| September 22, 2026 | 2.416 |
| September 21, 2026 | 2.449 |
| September 18, 2026 | 2.444 |
| September 17, 2026 | 2.486 |
| September 16, 2026 | 2.455 |
| September 15, 2026 | 2.453 |
| September 14, 2026 | 2.416 |
| September 11, 2026 | 2.415 |
| September 10, 2026 | 2.391 |
| September 09, 2026 | 2.421 |
| September 08, 2026 | 2.447 |
| September 04, 2026 | 2.458 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pfizer Inc. | 1.850 |
| Bristol Myers Squibb Co. | 5.540 |
| Tarsus Pharmaceuticals, Inc. | 38.05 |
| Seaport Therapeutics, Inc. | 2.691 |
| ANI Pharmaceuticals, Inc. | 2.568 |
Price to Book Value Related Metrics
| PE Ratio | 11.15 |
| PS Ratio | 2.012 |
| Price to Free Cash Flow | 6.556 |
| Price | 33.76 |
| Earnings Yield | 8.97% |
| Market Cap | 1.982B |
| Operating PE Ratio | 9.077 |
| Normalized PE Ratio | 11.15 |